BrianFGageMD

Professor, Internal Medicine, Washington University in St. Louis School of Medicine

Dr. Gage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Washington University Mailcode 8005-94-01
660 S. Euclid Ave
Saint Louis, MO 63110
Phone+1 314-362-5060

Fax+1 314-362-6959

Brian F Gage, MD, MSc is a Professor of Medicine at Washington University in St. Louis and an attending physician at Barnes-Jewish Hospital. He received his MD from University of California San Diego (UCSD) School of Medicine and his MSc in health services research from Stanford University. He has been in practice more than 20 years. He developed the CHADS2 stroke prediction rule for atrial fibrillation and the non-profit website www.WarfarinDosing.org. His publications have been cited more than 10,000 times.

Stanford UniversityMSc, Health Service Research, 1992 - 1994
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1991 - 1992
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1989 - 1991
University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1988 - 1989
University of California San Diego School of MedicineClass of 1988

PubMed

1076 citations
Estimation of the warfarin dose with clinical and pharmacogenetic data
Teri E. Klein, Russ B. Altman, Niclas Eriksson, Brian F. Gage, Stephen E. Kimmel
The New England Journal of Medicine. 2009-02-19
537 citations
A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
Stephen E. Kimmel, Benjamin French, Scott E. Kasner, Julie A. Johnson, Jeffrey L. Anderson
The New England Journal of Medicine. 2013-12-11
156 citations
Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.
Brian F. Gage, Elena Birman-Deych, Martha J. Radford, David S. Nilasena, Ellen F. Binder
Archives of Internal Medicine. 2006-01-23

Lectures

Case #5 Patient With AF and CAD Undergoing PCI: OAC Is Preferable to LAAO
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Missouri Construction Workers Face Frequent Injuries, Often Prescribed OpioidsJanuary 8th, 2021
Low-Intensity Warfarin Not Noninferior in Hip, Knee SurgeryNovember 5th, 2019
Anticoagulant Type May Influence Fracture Risk in A-fib PatientsOctober 21st, 2019
Join now to see all

Pharmacogenetic Refinement of the Warfarin Dose Using Machine LearningNHLBI2024–2028
Genetics-Informatics Trial (GIFT) Of Warfarin To Prevent DVTNational Heart, Lung, And Blood Institute2009–2011
Vitamin K, VKORC1 Polymorphisms, And Osteoporotic FracturesNational Center For Research Resources2007
Pharmacogenetics, Biomarkers, And Antithrombotic TherapyNational Center For Research Resources2006–2007
Pharmacogenetics, Biomarkers, And Antithrombotic TherapyNational Heart, Lung, And Blood Institute2003–2006
Thinrs ParticipantsNational Heart, Lung, And Blood Institute2004
Clinic ParticipantsNational Heart, Lung, And Blood Institute2004
Prevent ParticipantsNational Heart, Lung, And Blood Institute2004
Pharmacogenetics And Antithrombotic TherapyNational Heart, Lung, And Blood Institute2003
Pharmacogenetics And Antithrombotic TherapyNational Heart, Lung, And Blood Institute2002
Optimal Antithrombotic Therapy In Atrial FibrillationAgency For Healthcare Research And Quality1999–2001